Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 1,940,398 |
|
|||||
| News | (10) | ||||||
| Day High | 1.18 | Low High |
|||||
| Day Low | 1.10 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| FibroGen Inc | FGEN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.08 | -6.72% | 1.11 | 18:45:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.15 | 1.10 | 1.18 | 1.10 | 1.19 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,018 | 1,940,398 | US$ 1.13 | US$ 2,193,694 | - | 0.3333 - 18.6175 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:56:23 | 50 | US$ 1.1098 | USD |
FibroGen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 108.65M | 98.77M | - | 147.75M | -284.23M | -2.88 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
FibroGen News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FGEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.17 | 1.475 | 1.10 | 1.20 | 5,077,582 | -0.06 | -5.13% |
| 1 Month | 1.20 | 1.475 | 1.10 | 1.20 | 2,340,473 | -0.09 | -7.50% |
| 3 Months | 2.09 | 2.80 | 0.90105 | 1.43 | 2,481,296 | -0.98 | -46.89% |
| 6 Months | 0.5768 | 2.93 | 0.565 | 1.54 | 2,544,503 | 0.5332 | 92.44% |
| 1 Year | 18.60 | 18.6175 | 0.3333 | 1.89 | 3,157,646 | -17.49 | -94.03% |
| 3 Years | 21.39 | 30.1249 | 0.3333 | 6.94 | 1,709,452 | -20.28 | -94.81% |
| 5 Years | 38.49 | 57.2088 | 0.3333 | 14.15 | 1,343,049 | -37.38 | -97.12% |
FibroGen Description
| FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. |
